BioSpace News Archive

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced that its board of directors has amended its shareholder rights plan.

Synapse Medical Communications announced that its “AZOncologyID” website has been named the Gold winner of the 2019 PM360 Pharma Choice Awards, in the Professional Website category, and its “BiomARker Experience Augmented Reality” application has been named the Bronze winner in the Application category.

Today, at the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) 2020, Ascensia presented data from a study that assessed the performance of blood glucose monitoring systems (BGMSs) when used with mobile applications (apps) for diabetes management

Research Supported by Bay Area Lyme Foundation Evaluates Anti-microbial Effects of 14 Natural Products Compared to Antibiotics Used to Treat Lyme Disease [21-February-2020] MARIN, Calif. , Feb. 21, 2020 /PRNewswire/ -- Bay Area Lyme Foundation , a leading sponsor of Lyme disease research in the U.S., today announced the publication of new data finding that seven herb

Precision BioSciences, Inc. (Nasdaq: DTIL), a life sciences company dedicated to improving life through the application of its pioneering, proprietary ARCUS® platform, announced today that it will publish financial results for the fiscal year and fourth quarter of 2019 and provide a corporate update on March 10, 2020.

Cerus Endovascular Ltd., a privately-held, commercial stage medical device company, today announced that it has now successfully completed its Series B financing having raised a total of $19.0 million from current and new institutional investors since commencement of the round in July 2018.

Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSXV: ATE, OTCQB: ATBPF), a leader in developing safer, non-addictive therapeutics for pain and inflammation, is pleased to announce that it has been named a TSX Venture 50™ company for the second consecutive year, in recognition of its performance on the TSX Venture Exchange.

Bristol-Myers Squibb Company (NYSE: BMY) today announced Japan’s Ministry of Health, Labor and Welfare (MHLW) has approved Opdivo (nivolumab) for the treatment of patients with unresectable advanced or recurrent esophageal cancer that has progressed following chemotherapy.

GeneTex, a research antibody manufacturing company, is proud to announce the release of a novel recombinant rabbit monoclonal RAS (G12D mutant) antibody [HL10].

Aurinia Pharmaceuticals Inc. announced that Mr. Peter Greenleaf, President and Chief Executive Officer, will present a corporate overview at the 9th Annual SVB Leerink Global Healthcare Conference on Tuesday, February 25, 2019 at 10:00 a.m. ET in New York, NY.